TuisBNTX • NASDAQ
add
BioNTech SE - ADR
Vorige sluiting
$96,00
Dagwisseling
$95,21 - $96,69
Jaarwisseling
$81,20 - $129,27
Markkapitalisasie
23,14 mjd USD
Gemiddelde volume
1,05 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (EUR) | Sep. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 1,52 mjd | 22,02% |
Bedryfskoste | 1,40 mjd | 34,32% |
Netto inkomste | -28,70 m | -114,49% |
Netto winsgrens | -1,89 | -111,88% |
Wins per aandeel | -0,12 | -114,81% |
EBITDA | 91,20 m | 39,66% |
Effektiewe belastingkoers | 216,19% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (EUR) | Sep. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 14,53 mjd | -13,06% |
Totale bates | 21,34 mjd | -4,73% |
Totale aanspreeklikheid | 2,86 mjd | -12,87% |
Totale ekwiteit | 18,48 mjd | — |
Uitstaande aandele | 240,46 m | — |
Prys om te bespreek | 1,25 | — |
Opbrengs op bates | -0,38% | — |
Opbrengs op kapitaal | -0,44% | — |
Kontantvloei
Netto kontantverandering
| (EUR) | Sep. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | -28,70 m | -114,49% |
Kontant van bedrywe | 780,70 m | 222,19% |
Kontant van beleggings | -925,30 m | -551,16% |
Kontant van finansiering | -11,50 m | -45,57% |
Netto kontantverandering | -176,60 m | 76,52% |
Beskikbare kontantvloei | 1,05 mjd | 253,59% |
Meer oor
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes.
In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic. Wikipedia
HUB
Gestig
2008
Webwerf
Werknemers
6 772
